Dopamine dysregulation syndrome (DDS) is a relatively recently described iatrogenic
disturbance that may complicate long-term symptomatic therapy of Parkinson's disease …

Background To reduce prescribing cascades occurring in clinical practice, healthcare
providers require information on the prescribing cascades they can recognize and prevent …

Objective: To evaluate the risk of Parkinson disease (PD) among patients with depression by
using the Taiwan National Health Insurance Research Database (NHIRD). Methods: We …

We conducted a case‐control study to examine the association between depression and
Parkinson's disease (PD). Participants included 992 PD cases diagnosed after 2,000 and …

Background Neuroticism is linked to mood disorders and Alzheimer's disease, but fewer
studies have tested the prospective association with Parkinson's disease (PD). Objectives …

The misattribution of an adverse drug reaction (ADR) as a symptom or illness can lead to the
prescribing of additional medication, referred to as a prescribing cascade. The aim of this …

Background: Individuals with depression have a higher risk of Parkinson's disease (PD) but
the timing of the association is unknown. Therefore, the relationship between initiation of …

Objective To test the hypothesis of an increased incidence of antiparkinson drug prescribing
or Parkinson disease (PD) diagnostic codes after chronic lithium treatment compared with …

Background Substantia nigra hyperechogenicity (SNH) is a characteristic transcranial
sonography (TCS) finding in Parkinson's disease (PD). SNH, found also in about 10% of …

BACKGROUND: Lithium was the first clinically effective mood stabilizer marketed worldwide.
However, the medical literature suggests that lithium may have an indication as a …